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Abstract
Since the incidence of penicillin-resistant Streptococcus pneumoniae has been increasing at an astonishing rate throughout
the world, the need for accurate and rapid identification of pneumococci has become increasingly important to determine
the appropriate antimicrobial treatment. We have evaluated an immunochromatographic test (ODK-0901) that detects
pneumococcal antigens using 264 middle ear fluids (MEFs) and 268 nasopharyngeal secretions (NPSs). A sample was
defined to contain S. pneumoniae when optochin and bile sensitive alpha hemolytic streptococcal colonies were isolated by
culture. The sensitivity and specificity of the ODK-0901 test were 81.4% and 80.5%, respectively, for MEFs from patients with
acute otitis media (AOM). In addition, the sensitivity and specificity were 75.2% and 88.8%, respectively, for NPSs from
patients with acute rhinosinusitis. The ODK-0901 test may provide a rapid and highly sensitive evaluation of the presence of
S. pneumoniae and thus may be a promising method of identifying pneumococci in MEFs and NPSs.
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Introduction
Acute otitis media (AOM) is a common bacterial infection
during childhood and frequently accompanies acute rhinosinusitis.
By 3 years of ages, 50–70% of children have experienced at least
one episodes of AOM, with 15–20% of children suffering from
recurrent episodes of AOM [1,2]. Streptococcus pneumoniae is the
major bacterial cause of both AOM and acute rhinosinusitis,
followed by Haemophilus influenzae and Moraxella catarrhalis [3].
Simultaneous cultures from middle ear fluids (MEFs) and
nasopharyngeal secretions (NPSs) demonstrate the presence of
identical pathogens [4].
Antibiotics are prescribed frequently for initial treatment of
these infectious diseases. However, the choice of appropriate
antibiotics is difficult since there is no rapid and accurate
diagnostic test to identify the pathogen in the middle ear cavity.
As a result, selective pressure by the frequent use of empirical
antimicrobial treatment has increased the incidence of antibiotic-
resistant pathogens in childhood [5–8]. One alternative to
antibacterial therapy for physicians would be to observe the
affected children without administering antibiotics [9,10]. How-
ever, this alternative is undoubtedly accompanied by the risk of
worsening infections [11,12]. A safer approach to the treatment of
AOM and acute rhinosinusitis would be the accurate and rapid
determination of the causative pathogen such as S. pneumoniae
followed by prompt antibacterial therapy using antibiotics
appropriate for the detected pathogen. Identification of the
causative pathogen as early as possible and selection of a suitable
antibacterial drug are thus desirable to prevent persistent and
recurrent infections. Unfortunately, an effective tool for the rapid
diagnosis of middle ear infections had not yet been developed.
While bacterial culture with Gram stain is the gold standard for
identifying S. pneumoniae, bacterial culture requires several days to
complete [13–15]. In addition, the prior administration of antimicro-
bial agents reduces the ability of conventional bacterial cultures to
accurately identify the pathogen. An antigen detection test can
demonstrate the presence of non-viable bacteria. The latex agglutina-
tion test and countercurrent immunoelectrophoresis have both been
applied to S. pneumoniae identification, but both are insufficient as
routine diagnostic methods in general practice because of their lack of
sensitivity and specificity [16–19]. At present, polymerase chain
reaction (PCR) is considered the most sensitive and specific test, but it is
both expensive and requires a complicated process [20].
The rapid immunochromatograpy test for the urinary pneumo-
coccal antigen, the Binax NOWH Streptococcus pneumoniae test (Binax,
Inc., Portland, MA), shows high specificity (.90%) and high
sensitivity (50–80%) in adult pneumonia and is thus a useful tool for
identifying severe pneumococcal pneumonia in adults [21–23].
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and acute rhinosinusitis has limited value, especially for children.
Most children with pneumococcal AOM have antigen-negative
urine samples [24]. In addition, the majority of healthy children
carrying S. pneumoniae in the nasopharynx may have antigen-positive
urine samples [25–28]. In children who recently received
pneumococcal vaccination, the urinary test may be positive [29].
Sampling of urine of infants with AOM or rhinosinusitis may be
inconvenient. The Binax NOWH urinary antigen test and the
RAPIRUNH S.pneumoniae antigen detection test for sputum have
been adapted for respiratory infections [23,30–33].
The ODK-0901 test (Otsuka Pharmaceutical Co., Ltd., Tokyo,
Japan) is a diagnostic kit that uses polyclonal antibodies to detect
pneumococcal polysaccharides directly from MEFs and NPSs.
The present study was designed to evaluate the ability of ODK-
0901 test to detect S. pneumoniae among patients with AOM and
acute rhinosinusitis in a clinical setting.
Materials and Methods
Study populations
This case-control study was conducted between December 2009
to March 2010 in seven hospitals and clinics in Japan. Patients
with AOM and/or acute rhinosinusitis were eligible to be enrolled
into this study without regard to age and gender, previous or
current antimicrobial treatments, and inpatient or outpatient
status. Diagnostic criteria for AOM included an acute onset of
symptoms including ear pain, fever, and, for young children,
crying combined with abnormal tympanic membrane findings
with redness, bulging, and obliteration of landmarks. Specimens of
MEFs were collected with the ATOMSH tap middle ear aspirator
(LUMENIS Co., Ltd., Tokyo, Japan) or sterile swabs after
myringotomy under anesthesia of the tympanic membrane. The
diagnostic criteria for acute rhinosinusitis included acute onset of
symptoms including nasal discharge, headache/irritability, and
moist cough combined with postnasal discharge. Specimens of
NPSs were obtained with the ATOMSH tap or sterile swabs.
Immediately after testing via the ODK-0901 test and plating the
specimens for cultures, the samples were stored at 280uC until
real-time PCR was performed.
This study was approved by the Institutional Review Board of
the Ethical Committee of Nishinomiya Kyoritsu Neurosurgical
Hospital and Tohoku Rosai Hospital. Before collecting samples,
informed consent was obtained from the patients or from the
parents or guardians for pediatric patients.
Bacterial cultures
Bacterial culture was used as the gold standard for the presence
of S. pneumoniae in samples. Approximately 10 ml of sample
collected by sterile swabs was plated on blood and chocolate agar
plates and then incubated for 24 to 48 h at 37uC under a 5% CO2
environment according to standard laboratory procedures. S.
pneumoniae were identified by alpha-hemolysis and colony mor-
phology on 5% sheep blood agar, Gram stain characteristics,
optochin sensitivity, and bile solubility. H. influenzae were identified
by growth on chocolate agar, colony morphology, Gram stain
characteristics, and a growth requirement for X and V factors. M.
catarrhalis were identified by colony morphology, Gram stain
characteristics, and the biochemical reaction of butyrate esterase.
Detection of pneumococcal antigen by the ODK-0901
test
The ODK-0901 test uses rapid immunochromatography to
detect pneumococcal C-polysaccharides (teichoic acid) (C-ps (TA))
and capsular polysaccharides by rabbit anti-pneumococcal
polysaccharide polyclonal antibody immobilized on a nitrocellu-
lose membrane. After a 5-min extraction of the sample using the
extraction reagent, approximately 0.2 ml (4–5 drops) of the
extracted sample was applied to an additional reservoir cup and
incubated for 15 min with the ODK-0901 test at room
temperature.
If there are any pneumococcal C-ps (TA) and capsular
polysaccharides in the sample, it forms an immune complex with
gold-colloid-binding anti-pneumococcal polysaccharide polyclonal
antibody during the development of the sample and, subsequently,
produces a red line, which is complemented by anti-pneumococcal
polysaccharide polyclonal antibody on the test line. The gold-
colloid-labeled antibody not complemented on the test line
presents a red line complemented by anti-rabbit IgG goat
polyclonal antibody on the control line after it passed the test
line. Therefore, the sample is determined to be positive for
pneumococcal polysaccharide when two red lines appear and is
determined to be negative when there is only a control line. If the
control line does not appear, the sample should be retested.
Although the test requires approximately 15 minutes, if the two
test lines are observed within 15 minutes, the sample can be
determined to be positive.
Extractions of the 13 pneumococcal strains including D39 strain
serotype 2, TIGR4 strain serotype 4, EF3030 strain serotype 19F
and 10 clinical isolates of serotype 3, 6A (2 strains), 6B (2 strains),
4, 19A, 19F, 23F (2 strains) from the nasopharynx of children with
AOM were used as positive controls. As negative controls
extractions of 10 non-pneumococcal bacteria including nontype-
able H. influenzae (3 strains), Moraxella catarrhalis (3 strains),
Streptococcus pyogenes (4 strains) were used in this study.
The ODK-0901 test showed cross-reactivity only Streptococcus
mitis (1 strain) but not for other streptococcus species including S.
anginosus (1 strain), S. agalactiae (1 strain), S. constellatus (2 strains), S.
equi (1 strain), S. intermedius (2 strains), S. oralis (1 strain), and S.
sanguinis (1 strain). The ODK-0901 test also recognized the
purified LTA/TA, C-ps (the Statens Serum Institute, Copenha-
gen, Denmark) and typed purified pneumococcal capsular antigen,
type 1, 2, 3, 4, 5, 8, 9N, 12F, 14, 17F, 19F, 20, 22F, 23F, 25, 6B,
10A, 11A, 7F, and 15B (the American Type Culture Collection,
Manassas, VA) (manufacture data).
Real-time PCR
The detection of pneumococci by real-time PCR was done in
accordance with a previously reported assay procedure in Kitasato
Otsuka Biomedical Assay Laboratories, Kanagawa, Japan [32].
Briefly, total genomic DNA was extracted by the QIAamp DNA
Mini Kit (QIAGEN, Valencia, CA). The relative amount of
pneumococcal DNA genome was quantified by real-time PCR
using primers and the TaqMan probe established for the region of
the pspA gene of S. pneumoniae. Real-time PCR was then proceeded
on a thermal cycler ABI7700 or ABI7900 (Applied Biosystems,
Foster City, CA). The nucleotide sequences of the primers were as
follows: forward primer: 59-CAAGTCTAGCCAGCGTCGC-
TAT-39; reverse primer: 59-GGGAGATTCTTCTGCTCTTA-
CAAAAG-39,5 9-GGGAGATTCTTCTGCTCTTACCAAAG-
39, and 59-GGGAGATTCTTCTGCTCTTACAACAG-39; and
carboxyfluorescein-labeled probe: 59-(FAM)-CTGAGACGCAA-
CAAAACCAGCCCC-(TAMRA)-39,5 9-(FAM)-CTGAGACG-
TAACAAAACCAGCCCC-(TAMRA)-39 and 59-(FAM)-CGAA-
GACGCAACAAAACCAGCCCC-(TAMRA)-39. RNase free
water and DNA extracted from the S. pneumoniae ATCC6303
strain were used for negative and positive controls, respectively.
After an initial denaturation at 95uC for 15 min, the PCR reaction
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at 60uC for 1 min. Positive and negative controls were included for
every PCR run. The standard curves depended on the cycle
threshold (Ct) values of the positive controls. The number of copies
of the pspA gene in the samples was calculated based on the
standard curve. The sample with less than 40 copies was defined as
negative for real-time PCR.
Statistics
Statistical analysis was done by Prism 5 (GraphPad Software,
Inc., CA). A two tailed chi-square test or Fisher’s exact test was
used for categorical variables to test the significance of differences
between groups. The pneumococcal DNA densities were com-
pared by Mann-Whitney U test. A p-value of #0.05 was
considered statistically significant. A 95% confidential interval
(CI) was calculated.
Results
Populations
The 264 patients with AOM (250 with simple AOM and 14
with intractable OM) were enrolled in this study ranged in age
from 0 to 56 years with a median age of 1 year and included 117
females and 147 males. There were 257 children (0 to 14 years old)
and 7 adults (18 to 56 years old). The population of 268 patients
with acute rhinosinusitis enrolled in this study included 264
patients with acute rhinosinusitis and 4 patients with acute
exacerbation of chronic sinusitis and ranged in age from 0 to 75
years with a median age of 1 year. They were 249 children (0 to 14
years old) and 19 adults (18 to 75 year old). There were 124
females and 144 males. Two hundred and four patients had AOM
and acute rhinosinusitis concurrently. Because of the small
numbers of adult samples, we analyzed both MEF and NPS
samples without regarding ages of patients. Finally, we obtained
264 MEFs including 14 otorrhea samples from patients with AOM
and 268 NPSs from patients with acute rhinosinusitis.
Bacterial cultures
When the samples were tested via conventional bacterial
cultures, S. pneumoniae was identified in 59 samples out of 264
MEFs (22.3%). Of these 59 samples, 51 S. pneumoniae strains were a
single pathogen and 8 S. pneumoniae strains were combined with
other pathogens. Seven MEFs contained S. pneumoniae combined
with either or both H. influenzae and M. catarrhalis (6 MEFs
contained H. influenzae and oneMEF contained both H. influenzae
and M. catarrhalis). H. influenzae and M. catarrhalis were identified in
84 (31.8%) and 9 (3.4%) MEFs, respectively. In 96 (36.4%) MEFs,
no pathogenic bacteria were identified.
Out of 268 NPSs, S. pneumoniae was detected in 161 (60.1%)
samples. Twenty-six NPSs contained S. pneumoniae as a single
pathogen. In contrast to the MEF samples, for the NPS samples
134 strains were combined with either or both H. influenzae or M.
catarrhalis (41 NPSs contained H. influenzae, 36 NPSs contained M.
catarrhalis and 57 contained both pathogens). Only one strain was
combined with other pathogenic bacteria. H. influenzae and M.
catarrhalis were identified in 159 (59.3%) and 139 (51.9%) NPSs,
respectively. No pathogenic bacteria were identified in 16 NPSs.
Sensitivity and specificity of the ODK-0901 test for MEFs
and NPSs
When the samples were evaluated with the ODK-0901 test, the
pneumococcal antigen was detected in 88 (33.3%) MEFs.
Compared with results obtained by conventional bacterial culture,
the sensitivity, specificity, positive predicting value, and negative
predicting value of the ODK-0901 test for MEFs were 81.4%
(95% CI: 71.4%–91.2%), 80.5% (95% CI: 75.0%–85.9%), 54.5%
(95% CI: 44.1%–64.9%), and 93.8% (95% CI: 90.1%–97.3%),
respectively (Table 1).
On the other hand, the pneumococcal antigen was detected in
133 (49.6%) NPSs. The sensitivity was 75.2% (95% CI: 68.4%–
81.8%), the specificity was 88.8% (95% CI: 82.8%–94.7%), and
the positive and negative predicting values were 91.0% (95% CI:
86.1%–95.8%) and 70.4% (95% CI: 62.6%–78.0%) for NPSs,
respectively, when compared with the results of conventional
bacterial cultures (Table 1).
Influence of prior antimicrobial treatment on the ODK-
0901 test
The sensitivity and specificity of the ODK-0901 test for MEFs
of patients who had undergone prior antimicrobial treatment were
further evaluated. We defined ‘‘prior antimicrobial treatment’’ as
antimicrobial treatment within 4 weeks before the MEFs and
NPSs were obtained. The sensitivity, specificity, positive predicting
value, and negative predicting value of the ODK-0901 test on
MEFs from patients with prior antimicrobial treatment compared
with from patients without prior antimicrobial treatment were
80.0% (95% CI: 59.7%–100%), 82.6% (95% CI: 73.6%–91.5%),
50.0% (95% CI: 30.0%–70.0%), and 95.0% (95% CI: 89.4%–
100%) compared with 81.8% (95% CI: 70.4%–93.2%), 79.4%
(95% CI: 72.6%–86.2%), 56.3% (95% CI: 44.1%–68.4%), and
93.1% (95% CI: 88.4%–97.7%), respectively (Table 2). The
sensitivity, specificity, positive predicting value, and negative
predicting value of the ODK-0901 test on NPSs from patients
with prior antimicrobial treatment compared with patients without
prior antimicrobial treatment were 67.4% (95% CI: 53.8%–
80.9%), 90.0% (95% CI: 79.2%–100%), 91.2% (95% CI: 81.6%–
100%), and 64.3% (95% CI: 49.7%–78.7%) compared with
78.3% (95% CI: 70.7%–85.8%), 88.3% (95% CI: 81.1%–95.4%),
90.9% (95% CI: 85.2%–96.5%), and 73.1% (95% CI: 64.1%–
82.1%), respectively (Table 3). There were no statistically
significant differences between the sensitivity, specificity, positive
predicting value, and negative predicting value of the MEFs and
NPSs from patients with prior antimicrobial treatment and those
from patients without prior antimicrobial treatment. However, a
tendency was observed for the sensitivity of the ODK-0901 test to
decrease for NPSs from patients with prior antimicrobial
treatment.
Quantification of the pspA gene in MEFs and NPSs by
real-time PCR
The number of pspA gene copies in MEFs was significantly
higher among samples positive for the ODK-0901 test than among
those of samples negative for the ODK-0901 test (p,0.001)
(Fig. 1A). The median number of pspA gene copies in ODK-0901-
Table 1. Sensitivity and specificity of the ODK-0901 test for
MEFs and NPSs.
Culture for NPSs Culture for MEFs
Positive Negative Total Positive Negative Total
ODK-0901 Positive 48 40 88 121 12 133
Negative 11 165 176 40 95 135
Total 59 205 264 161 107 268
doi:10.1371/journal.pone.0033620.t001
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5 copies/mg DNA and
40 copies/mg DNA, respectively. Sixty-four (36.4%) out of 176
MEFs negative for the ODK-0901 test contained the pspA gene,
but 11 (6.3%) of them showed the growth of S. pneumoniae by the
conventional culture. Nine (10.2%) out of 88 MEFs positive for the
ODK-0901 test did not present the pspA gene. Only 1 (1.1%) MEF
among the samples was positive by culture but not by the ODK-
0901 test. There were no significant differences between the
numbers of pspA gene copies in MEFs with or without prior
antimicrobial treatment. The median number of pspA gene copies
in ODK-0901-positive MEFs from patient having prior antimi-
crobial treatment compared with the median number from
patients without prior antimicrobial treatment was 7.5610
5
copies/mg DNA versus 8.0610
5 copies/mg DNA.
The number of pspA gene copies in the ODK-0901-positive
NPSs was also significantly higher than the number of copies in the
ODK-0901-negative NPSs (p,0,001) (Fig. 1B). The median
numbers of pspA gene copies in ODK-0901-positive and -negative
NPSs were 2.0610
6 copies/mg DNA and 40 copies/mg DNA,
respectively. Similar to the results from MEFs, the number of pspA
gene copies in NPSs exhibiting growth of S. pneumoniae was
significantly higher than the number of copies in NPSs negative for
S. pneumoniae by culture (p,0.001). Fifty-six (41.5%) out of 135
ODK-0901-negative NPSs contained the pspA gene, and 34
(25.2%) of them were culture positive. Seven (5.3%) out of 133
NPSs positive for the ODK-0901 test did not have the pspA gene,
but only 2 (1.5%) of them were culture positive. The median
numbers of pspA gene copies in ODK-0901-positive NPSs from
both patients having prior antimicrobial treatment and patients
without prior antimicrobial treatment were 4.0610
6 copies/mg
DNA.
Predictive value for middle ear pneumococci by
evaluating nasopharyngeal secretions
For 204 cases of AOM, we evaluated the ability of the ODK-
0901 test on NPSs to accurately make a bacteriologic assessment of
AOM when compared with the bacteriologic assessment resulting
from conventional bacterial cultures. The positive and negative
predictive values of nasopharyngeal conventional bacterial cul-
tures to detect the presence of pneumococci in MEFs were 31.6%
(95% CI: 23.6%–39.4%) and 100%, respectively. In contrast, the
positive and negative predictive values of the ODK-0901 test to
detect the presence of pneumococci in MEFs were 32.7% (95%
CI: 23.8%–41.6%) and 92.8% (95% CI: 87.6%–97.9%), respec-
tively (Table 4). There were no statistically significant differences
between the abilities of conventional bacterial cultures and the
ODK-0901 test to negatively predict middle ear pathogens.
Discussion
Some attempts have been made to develop an immunochro-
matographic test suitable for the rapid detection of pneumococci
in MEFs and NPSs in clinical situations. The advantage of such a
test would be its ability to allow physicians to make earlier and
more accurate decisions concerning the appropriate antimicrobial
treatment for patients with AOM [24,34–37]. In the present study,
we evaluated the clinical significance of a novel immunochroma-
tographic ODK-0901 test that would allow the rapid and accurate
detection of pneumococci in MEFs and NPSs.
The ODK-0901 test works better than bacterial culture in
detecting the presence of S. pneumoniae because it recognizes C-ps
(TA) and capsular polysaccharides from S. pneumoniae, even though
S. pneumoniae have died out by prior antimicrobial treatment or
inappropriate culture conditions. Further, no cross-reactivity was
seen with type b H. influenzae contained phosphorylcholine,
suggesting that the antibody did not react with phosphorylcholine
carried in C-ps [38–40].
In this study, conventional bacterial cultures showed that 22.3%
of MEFs and 60.1% of NPSs contained viable S. pneumoniae.I n
contrast, the ODK-0901 test used for the study detected S.
pneumoniae antigen in 33.3% of MEFs and 49.6% of NPS. The
ODK-0901 test yielded 81.4% sensitivity and 80.5% specificity for
MEFs and 75.2% sensitivity and 88.8% specificity for NPSs.
Faden et al. first reported the application of the Binax NOW test
for detecting S. pneumoniae in MEFs from otitis media with effusion
(OME) with a sensitivity of 80.0% and a specificity of 83.0% [35].
On the other hands, Gisselesson-Solen et al. reported that the
Binax NOW test had the relatively high sensitivity of 90.5% and
specificity of 82.4% for severe AOM and associated complications
Table 2. Sensitivity and specificity of the ODK-0901 test for MEFs depending on prior antimicrobial treatment.
With prior treatment Without prior treatment
Culture positive Culture negative total Culture positive Culture negative Total
ODK-0901 Positive 12 12 24 36 28 64
Negative 3 57 60 8 108 116
Total 15 69 84 44 136 180
doi:10.1371/journal.pone.0033620.t002
Table 3. Sensitivity and specificity of the ODK-0901 test for NPSs depending on prior antimicrobial treatment.
With prior treatment Without prior treatment
Culture positive Culture negative total Culture positive Culture negative Total
ODK-0901 Positive 31 3 34 90 9 99
Negative 15 27 42 25 68 93
Total 46 30 76 115 77 192
doi:10.1371/journal.pone.0033620.t003
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sensitivity and specificity of the ODK-0901 test with the previous
results by the Binax NOW test. The ODK-0901 test can directly
apply to MEFs and may prove useful in selecting the most
appropriate therapy for AOM. In contrast, the sensitivity of ODK-
0901 test for NPSs was low at 75.2%. The sensitivity and
specificity of the Binax NOW test in previous reports varied from
92.2% to 95.0% and from 78.0% to 97.7%, respectively [34,41].
Eleven samples out of 264 MEFs and 40 samples out of 268
NPSs exhibited false negatives to the ODK-0901 test due to the
lower quantity of pneumococci in those MEFs and NPSs.
Relatively small amounts of sample collected by swabs may lead
to the false negative results for the ODK-0901 test. Some patients
in this study with inconsistent ODK-0901 test results were
concurrently undergoing or had undergone treatment with
antibiotics. However, the study found that whether the patients
had or had not undergone prior antimicrobial treatment made no
differences in the pneumococcal density in MEFs and NPSs. As
results, there were no differences in sensitivity and specificity of the
ODK-0901 test based on the presence or absence of prior
antimicrobial treatment. However, in particular, the ability of the
ODK-0901 test to detect pneumococcal antigens in NPSs tended
to be affected but not statistically significantly by the presence or
absence of previous antibiotic treatment. Another possibility will
be degeneration of polysaccharides of non-viable S. pneumoniae cells
because real-time PCR indicated the presence of a relatively small
amount of pneumococcal DNA.
In contrast, false positives were observed in 40 MEFs and 12
NPSs. Like the Binax NOW test, the ODK-0901 test has already
been confirmed to exhibit cross-reactivity with S. mitis, part of the
bacterial flora of pharynx (manufacture data) [42–44]. However,
alpha-streptococcus species including S. mitis was not identified in
the MEFs from the 40 false positive patients. Another possibility is
that S. pneumoniae in MEFs are affected by various products of
inflammation. Thus, the pathogen sometimes does not grow well
in conventional culture tests and is thus very difficult to identify.
The samples for the 75% of the MEFs and NPSs that were false
positive for the ODK-0901 test but were found to contain
pneumococcal DNA via real-time PCR may have been of such
degraded quality that bacterial culture was not able to detect S.
Figure 1. Distribution of the number of copies of pspA gene in MEF and NPS depending on prior antimicrobial treatment and the
ODK-0901 test. The pneumococcal pspA gene was quantified by real-time PCR and the distribution was expressed. Open circles are culture-
negative specimens. Closed circles are culture-positive specimens. A) Middle ear fluid; B) nasopharyngeal secretion.
doi:10.1371/journal.pone.0033620.g001
Table 4. Prediction of middle ear pathogen by
nasopharyngeal test.
Middle ear fluid culture
Positive Negative Total
Nasopharyngeal
secretion
Culture Positive 42 91 133
Negative 0 71 71
ODK-0901 Positive 35 72 107
Negative 7 90 97
Total 42 162 204
doi:10.1371/journal.pone.0033620.t004
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as well as real-time PCR may be effective in S. pneumoniae with low
biological activity. Furthermore, it is possible that some of the false
positive samples contained a PspA null strain, which would result
in the sample being negative for pspA gene via real-time PCR.
Samples of 9 MEF and 7 NPSs were found to be negative by real-
time PCR but were found to be positive by culture.
Since S. pneumoniae is one of the normal inhabitants of the
nasopharynxes of children, its presence may create positives for
antigen detection. Thus, the ODK-0901 test’s detection of
indigenous S. pnuemoniae in the nasopharynx will lead to
overdiagnosis. In the current study, we further evaluated the
pneumococcal DNA density in both MEFs and NPSs. The volume
of MEFs obtained from AOM children is usually small and
contains only a small number of organisms. It is important to
evaluate the pneumococcal density in both types of specimens.
Our study’s use of real-time PCR proved that the ODK-0901 test
yielded a positive result when the pneumococcal bacteria load was
high at the affected site. Our previous study of nasopharyngeal
carriage used real-time PCR to show that about 65% of children
with upper respiratory infection had S. pneumoniae in the
nasopharynx while conventional bacterial cultures of the same
samples indicated that only 61% of the children were positive [45].
In practice, MEFs is not always available, and so nasopharyngeal
secretions are sometimes used for bacteriological documentation.
With the goal of using samples from nasopharyngeal colonization
to predict the organism causing AOM, we evaluated the
sensitivity, specificity, positive predictive value, and negative
predictive value of culture test results from samples of middle
ear fluid and nasopharyngeal secretions. We found essentially the
same results as previous reports [24,34,35,41]. It was reported that
nasopharyngeal cultures has meaningful negative predicting value
for determining middle ear pathogens [46,47]. Based on the results
of middle ear cultures as the gold standard, negative predicting
value for S. pnuemoniae in MEFs were 100% by cultures and 92.8%
by the ODK-0901 test, respectively.
The ODK-0901 test can thus be expected to be useful in infants
from whom middle ear fluid cannot be collected. Because AOM
may become persistent in young children, administration of
appropriate antibiotics at an early stage of the treatment becomes
especially important in both disease treatment and in the
prevention of the development of drug-resistant bacteria. The
current immunochromatography ODK-0901 test can become an
important tool to help in the more rapid diagnosis of S. pneumoniae
infections and in the subsequent administration of appropriate
antibiotics earlier in the treatment cycle than was previously
possible.
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